N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl]-4-methyl-2-propan-2-ylfuran-3-carboxamide
C20H16ClF2N3O4 — CID 90394531
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl]-4-methyl-2-propan-2-ylfuran-3-carboxamide
N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl]-4-methyl-2-propan-2-ylfuran-3-carboxamide (PubChem CID 90394531) has the molecular formula C20H16ClF2N3O4 and a molecular weight of 435.81 g/mol. Its IUPAC name is N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl]-4-methyl-2-propan-2-ylfuran-3-carboxamide.
Molecular Properties
| Compound Name | N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl]-4-methyl-2-propan-2-ylfuran-3-carboxamide |
|---|---|
| PubChem CID | 90394531 |
| Molecular Formula | C20H16ClF2N3O4 |
| Molecular Weight | 435.81 g/mol |
| Exact Mass | 435.08 |
| IUPAC Name | N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl]-4-methyl-2-propan-2-ylfuran-3-carboxamide |
| SMILES | Cc1coc(C(C)C)c1C(=O)Nc1cnc(-c2cc3c(cc2Cl)OC(F)(F)O3)cn1 |
| InChI | InChI=1S/C20H16ClF2N3O4/c1-9(2)18-17(10(3)8-28-18)19(27)26-16-7-24-13(6-25-16)11-4-14-15(5-12(11)21)30-20(22,23)29-14/h4-9H,1-3H3,(H,25,26,27) |
| InChIKey | XRZZWNKXMNPCJI-UHFFFAOYSA-N |
| XLogP | 5.40 |
| TPSA | 86.48 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 435.81 |
| LogP ≤ 5 | 5.40 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 90394531 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.